Search Results - "Britain, Colleen M"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor by Holdbrooks, Andrew T., Britain, Colleen M., Bellis, Susan L.

    Published in The Journal of biological chemistry (02-02-2018)
    “…Activation of the tumor necrosis factor receptor 1 (TNFR1) death receptor by TNF induces either cell survival or cell death. However, the mechanisms mediating…”
    Get full text
    Journal Article
  2. 2

    Transfer of Functional Cargo in Exomeres by Zhang, Qin, Higginbotham, James N., Jeppesen, Dennis K., Yang, Yu-Ping, Li, Wei, McKinley, Eliot T., Graves-Deal, Ramona, Ping, Jie, Britain, Colleen M., Dorsett, Kaitlyn A., Hartman, Celine L., Ford, David A., Allen, Ryan M., Vickers, Kasey C., Liu, Qi, Franklin, Jeffrey L., Bellis, Susan L., Coffey, Robert J.

    Published in Cell reports (Cambridge) (16-04-2019)
    “…Exomeres are a recently discovered type of extracellular nanoparticle with no known biological function. Herein, we describe a simple ultracentrifugation-based…”
    Get full text
    Journal Article
  3. 3

    The Glycosyltransferase ST6Gal-I Protects Tumor Cells against Serum Growth Factor Withdrawal by Enhancing Survival Signaling and Proliferative Potential by Britain, Colleen M., Dorsett, Kaitlyn A., Bellis, Susan L.

    Published in The Journal of biological chemistry (17-03-2017)
    “…A hallmark of cancer cells is the ability to survive and proliferate when challenged with stressors such as growth factor insufficiency. In this study, we…”
    Get full text
    Journal Article
  4. 4

    Sialylation of EGFR by the ST6Gal-I sialyltransferase promotes EGFR activation and resistance to gefitinib-mediated cell death by Britain, Colleen M, Holdbrooks, Andrew T, Anderson, Joshua C, Willey, Christopher D, Bellis, Susan L

    Published in Journal of ovarian research (05-02-2018)
    “…The ST6Gal-I sialyltransferase is upregulated in numerous cancers, and high expression of this enzyme correlates with poor patient prognosis in various…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Glycosyltransferase ST6Gal-I promotes the epithelial to mesenchymal transition in pancreatic cancer cells by Britain, Colleen M., Bhalerao, Nikita, Silva, Austin D., Chakraborty, Asmi, Buchsbaum, Donald J., Crowley, Michael R., Crossman, David K., Edwards, Yvonne J.K., Bellis, Susan L.

    Published in The Journal of biological chemistry (01-01-2021)
    “…ST6Gal-I, an enzyme upregulated in numerous malignancies, adds α2-6-linked sialic acids to select membrane receptors, thereby modulating receptor signaling and…”
    Get full text
    Journal Article
  7. 7

    Role of the ST6GAL1 sialyltransferase in regulating ovarian cancer cell metabolism by Jones, Robert B, Silva, Austin D, Ankenbauer, Katherine E, Britain, Colleen M, Chakraborty, Asmi, Brown, Jamelle A, Ballinger, Scott W, Bellis, Susan L

    Published in Glycobiology (Oxford) (06-10-2023)
    “…Abstract The ST6GAL1 sialyltransferase, which adds α2–6-linked sialic acids to N-glycosylated proteins, is upregulated in many malignancies including ovarian…”
    Get full text
    Journal Article
  8. 8

    Receptor Sialylation by ST6Gal-I Promotes Tumor Progression by Enhancing Tumor Cell Survival and Epithelial to Mesenchymal Transition by Britain, Colleen M

    Published 01-01-2019
    “…The upregulation of a certain subset of glycosyltransferases was an early marker for cancer development. Specifically, ST6Gal-I, which adds an α2-6 linked…”
    Get full text
    Dissertation
  9. 9

    Glycosyltransferase ST6Gal-I promotes the epithelial to mesenchymal transition in pancreatic cancer cells by Britain, Colleen M, Bhalerao, Nikita, Silva, Austin D, Chakraborty, Asmi, Buchsbaum, Donald J, Crowley, Michael R, Crossman, David K, Edwards, Yvonne J K, Bellis, Susan L

    Published in The Journal of biological chemistry (23-11-2020)
    “…ST6Gal-I, an enzyme upregulated in numerous malignancies, adds α2-6-linked sialic acids to select membrane receptors, thereby modulating receptor signaling and…”
    Get full text
    Journal Article